This proof-of-concept randomized controlled clinical trial explores the safety, feasibility, and preliminary efficacy of psilocybin therapy versus treatment-as-usual among individuals being treated for methamphetamine use disorder.
MDMA-Assisted Group Therapy for Veterans with PTSD
This proof-of-concept clinical trial explores the safety and feasibility of MDMA-assisted psychotherapy conducted in a group therapy format among Veterans with PTSD.
We conducted a focus group regarding trauma-related mental health experiences among gender diverse individuals in order to inform a more inclusive approach to the development of new treatments for PTSD.
Stay tuned for more...
Funded by OHSU Psychiatry Research Seed Money Grant
Sponsor: Department of Veteran Affairs, Clinical Science Research & Development, Federal Award #IK2CX001495
The Stimulant Oxytocin Study is a randomized clinical trial of intranasal oxytocin for Veterans with co-occurring opioid and stimulant use disorders. Clinical outcomes include: substance use craving, treatment engagement, and stress reactivity.